Literature DB >> 12572862

Possible involvement of neutrophil elastase in impaired mucosal repair in patients with ulcerative colitis.

Yuji Kuno1, Kenji Ina, Tsuyoshi Nishiwaki, Tomoyuki Tsuzuki, Masaaki Shimada, Akira Imada, Yuji Nishio, Kazuo Nobata, Takefumi Suzuki, Takafumi Ando, Kenji Hibi, Akimasa Nakao, Tadashi Yokoyama, Yasuhisa Yokoyama, Kazuo Kusugami.   

Abstract

BACKGROUND: Little information is available on the relative contribution of peptide growth factors and leukocyte-derived proteinases to the repair processes in inflammatory bowel disease (IBD). We investigated their possible roles in epithelial cell restitution and proliferation in patients with IBD.
METHODS: The expression of hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), transforming growth factor-beta (TGF-beta), and neutrophil elastase (NE) was examined in colonic mucosal tissues. The effects of organ culture supernatants of mucosal tissues on epithelial cell restitution and proliferation were analyzed in vitro using an intestinal cell line, IEC-6 cells.
RESULTS: Most organ cultures detected the presence of measurable levels of HGF, with a relative paucity of KGF and TGF-beta activity. Greater levels of HGF were obtained in the mucosa involved with IBD, especially in patients with ulcerative colitis (UC). The mucosa involved with UC also showed higher amounts of NE. The supernatants from the mucosa involved with UC possessed a prominent stimulatory effect on the restitution of IEC-6 cells. By contrast, significant suppression beyond baseline levels was observed for the proliferation of IEC-6 cells when they were incubated with recombinant HGF plus the supernatants from the mucosa involved with UC. This suppression was diminished considerably by preincubation of the supernatants with the anti-NE antibody.
CONCLUSIONS: HGF produced in the intestinal mucosa may be an important stimulator acting on epithelial cell restitution in patients with IBD. However, NE released in situ may impair mucosal repair through inhibiting epithelial cell proliferation in patients with UC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12572862     DOI: 10.1007/BF03326409

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  29 in total

1.  Mechanisms of tissue protection and repair in inflammatory bowel disease.

Authors:  W F Stenson
Journal:  Curr Opin Gastroenterol       Date:  2001-07       Impact factor: 3.287

2.  Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease.

Authors:  T Sakai; K Kusugami; H Nishimura; T Ando; T Yamaguchi; M Ohsuga; K Ina; A Enomoto; Y Kimura; Y Yoshikai
Journal:  Gastroenterology       Date:  1998-06       Impact factor: 22.682

3.  Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site.

Authors:  K Nakajima; J C Powers; B M Ashe; M Zimmerman
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

4.  Coordinate upregulation of interleukin-8 and growth-related gene product-alpha is present in the colonic mucosa of inflammatory bowel.

Authors:  A Imada; K Ina; M Shimada; T Yokoyama; Y Yokoyama; Y Nishio; T Yamaguchi; T Ando; K Kusugami
Journal:  Scand J Gastroenterol       Date:  2001-08       Impact factor: 2.423

5.  Clinical evaluation of hepatocyte growth factor in patients with gastrointestinal and pancreatic diseases with special reference to inflammatory bowel disease.

Authors:  M Matsuno; G Shiota; K Umeki; H Kawasaki; H Kojo; K Miura
Journal:  Res Commun Mol Pathol Pharmacol       Date:  1997-07

6.  Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease.

Authors:  P W Finch; V Pricolo; A Wu; S D Finkelstein
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

7.  Hepatocyte growth factor accelerates the wound repair of cultured gastric mucosal cells.

Authors:  S Watanabe; M Hirose; X E Wang; K Maehiro; T Murai; O Kobayashi; A Nagahara; N Sato
Journal:  Biochem Biophys Res Commun       Date:  1994-03-30       Impact factor: 3.575

8.  Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers.

Authors:  C Ciacci; S E Lind; D K Podolsky
Journal:  Gastroenterology       Date:  1993-07       Impact factor: 22.682

9.  Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.

Authors:  K Kyokane; M Ito; Y Sato; K Ina; T Ando; K Kusugami
Journal:  J Pathol       Date:  1998-04       Impact factor: 7.996

10.  Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.

Authors:  M W Babyatsky; G Rossiter; D K Podolsky
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  12 in total

1.  Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis.

Authors:  Colm B Collins; Carol M Aherne; Stefan F Ehrentraut; Mark E Gerich; Eóin N McNamee; Martine C McManus; Matthew D P Lebsack; Paul Jedlicka; Tania Azam; Edwin F de Zoeten; Charles A Dinarello; Jesús Rivera-Nieves
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

2.  Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis.

Authors:  Yuichi Morohoshi; Katsuyoshi Matsuoka; Hiroshi Chinen; Nobuhiko Kamada; Toshiro Sato; Tadakazu Hisamatsu; Susumu Okamoto; Nagamu Inoue; Hiromasa Takaishi; Haruhiko Ogata; Yasushi Iwao; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2006-04       Impact factor: 6.772

3.  Neutrophil elastase in colitis: more than a marker of disease activity?

Authors:  Ryota Hokari; Soichiro Miura
Journal:  J Gastroenterol       Date:  2006-04       Impact factor: 6.772

Review 4.  The Dual Role of Neutrophils in Inflammatory Bowel Diseases.

Authors:  Odile Wéra; Patrizio Lancellotti; Cécile Oury
Journal:  J Clin Med       Date:  2016-12-17       Impact factor: 4.241

Review 5.  Understanding the Multifaceted Role of Neutrophils in Cancer and Autoimmune Diseases.

Authors:  Xu Wang; Lin Qiu; Ziyi Li; Xiang-Yang Wang; Huanfa Yi
Journal:  Front Immunol       Date:  2018-11-09       Impact factor: 7.561

6.  Estrogen-related receptor alpha (ERRα) is a key regulator of intestinal homeostasis and protects against colitis.

Authors:  Allan Tran; Charlotte Scholtes; Mario Songane; Claudia Champagne; Luc Galarneau; Marie-Pier Levasseur; Nassima Fodil; Catherine Rosa Dufour; Vincent Giguère; Maya Saleh
Journal:  Sci Rep       Date:  2021-07-23       Impact factor: 4.379

7.  Polyphenol-Enriched Extracts of Prunus spinosa Fruits: Anti-Inflammatory and Antioxidant Effects in Human Immune Cells Ex Vivo in Relation to Phytochemical Profile.

Authors:  Anna Magiera; Monika Ewa Czerwińska; Aleksandra Owczarek; Anna Marchelak; Sebastian Granica; Monika Anna Olszewska
Journal:  Molecules       Date:  2022-03-04       Impact factor: 4.411

8.  Neutrophil Extracellular Trap Density Increases With Increasing Histopathological Severity of Crohn's Disease.

Authors:  Angie L Schroder; Belal Chami; Yuyang Liu; Chloe M Doyle; Mary El Kazzi; Golo Ahlenstiel; Gulfam Ahmad; Nimalan Pathma-Nathan; Geoff Collins; James Toh; Andrew Harman; Scott Byrne; Grahame Ctercteko; Paul K Witting
Journal:  Inflamm Bowel Dis       Date:  2022-03-30       Impact factor: 7.290

9.  Application of a chemical probe to detect neutrophil elastase activation during inflammatory bowel disease.

Authors:  Bethany M Anderson; Daniel P Poole; Luigi Aurelio; Garrett Z Ng; Markus Fleischmann; Paulina Kasperkiewicz; Celine Morissette; Marcin Drag; Ian R van Driel; Brian L Schmidt; Stephen J Vanner; Nigel W Bunnett; Laura E Edgington-Mitchell
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

10.  High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures.

Authors:  Jiani Wang; Christina Ortiz; Lindsey Fontenot; Ying Xie; Wendy Ho; S Anjani Mattai; David Q Shih; Hon Wai Koon
Journal:  PLoS One       Date:  2020-04-14       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.